LONDON (MMD Newswire) October 24, 2012 -- TCA Global Credit Master Fund today announced it has entered into a financing facility with Muscle Pharm Corp. (MSLP.OTCBB). Under the terms of the Agreement, TCA has committed to fund Muscle Pharm Corporation $2,000,000 USD via a Senior Secured Debenture and Committed Equity Facility.
Muscle Pharm founder and CEO Brad J. Pyatt has set his nutritional supplement company apart from the rest by making Muscle Pharm the "healthy lifestyle company that truly lives and breathes the healthy lifestyle". They are known for their development of supplements which are totally free of all banned substances.
Headquartered in Denver, Colorado the company is sold worldwide with major retail distributors including GNC, Vitamin Shoppe, Amazon.com, Bodybuilding.com, and Dick's Sporting Goods.
Founder, Mr. Pyatt, states, "our products are the result of years of exhaustive research at the Muscle Pharm Sports Science Center Research Institute. Top nutritional scientists and doctors utilized an advanced six-stage research protocol, then field-tested each supplement with the help of hundreds of professional athletes from the National Football League, Mixed Martial Arts, and Major League Baseball."
In 2012 Muscle Pharm was nominated for 18 Bodybuilding.com Supplement Awards. Muscle Pharm also has a partnership with MMA Elite resulting in the launch of an "MMA Elite product line". The company seeks to continue to expand its exposure and build the brand.
The credit facility provided through TCA Global Credit Master Fund ("TCA Fund") seeks to provide financing to small, growing, private and listed companies.
TCA Fund Management Group as the Investment Manager for TCA Global Credit Master Fund acts as an advisor to many small companies from its offices in the United States, United Kingdom, and Australia. TCA is a short duration, absolute return fund specializing in senior secured lending to small, mainly listed companies in the U.S., Canada, Western Europe and Australia. The team has a level of domestic and cross-border expertise, long-standing experience, and funding innovations, as is reflected in the number of transactions completed. This is a specialist business with an investment approach that fills an important finance gap in many leading markets. TCA Global Credit Master Fund provides a unique conduit for investors seeking uncorrelated returns in the small cap debt universe.
More about Muscle Pharm Corporation www.musclepharm.com
More about TCA Global Credit Master Fund www.trafcap.com
Forward Looking Statements & Disclaimer
This press release includes statements that constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Reform Act"). TCA Fund Management Group claims the protection of the safe-harbor for forward-looking statements contained in the Reform Act. These forward-looking statements are often characterized by the terms "may," "believes," "projects," "expects," or "anticipates," and do not reflect historical facts.
Specific forward-looking statements contained in this press release include, but are not limited to: impact of the company's expansion plan, and new business development success, future financial results, development and acquisition of new product lines, the impact of competitive products or pricing from technological changes, the effect of economic conditions and other uncertainties.
This document is being furnished by TCA Fund Management Group the investment manager ("Manager") of TCA Global Credit Master Fund LP (the "Fund" "TCA") solely for use in connection with consideration of an investment in the Fund by prospective investors. The information contained herein does not constitute an offer to sell or the solicitation of an offer to purchase any security or investment product. Any such offer or solicitation may only be made by means of delivery of an approved confidential offering memorandum and only in those jurisdictions where permitted by law. Prospective investors should inform themselves and take appropriate advice as to any applicable legal requirements and any applicable taxation and exchange control regulations in the countries of their citizenship, residence or domicile which might be relevant to the subscription, purchase, holding, exchange, redemption or disposal of any investments. The information contained herein does not take into account the particular investment objectives or financial circumstances of any specific person who may receive it. Before making an investment, prospective investors are advised to thoroughly and carefully review the offering memorandum with their financial, legal and tax advisers to determine whether an investment such as this is suitable for them. There is no guarantee that the investment objectives of the Fund will be achieved. No statement herein supersedes any statement to the contrary in the Fund's confidential offering emails. All information contained herein is confidential. This document may not be reproduced or copied without the prior written consent of the Manager. This document is subject to revision at any time and the Manager is not obligated to inform you of any changes made. The performance representations contained herein are not representations that such performance will continue in the future or that any investment scenario or performance will even be similar to such or description. In fact, there may be sharp differences between prior performance results of related funds; such performance should not be construed as an indicator of future performance of the Fund. Performance information and/or results, unless otherwise indicated, are un-audited and their appearance in this email reflects the estimated returns net of all expenses, including the management and performance fees similar to those of the Fund. Certain information contained in this material constitutes forward-looking statements, which can be identified by the use of forward-looking terminology such as "may," "will," "should," "expect," "anticipate," "target," "project," "estimate," "intend," "continue," or "believe," or the negatives thereof or other variations thereon or comparable terminology. Such statements are not guarantees of future performance or activities. Due to various risks and uncertainties, actual events or results or the actual performance of the Fund described herein may differ materially from those reflected or contemplated in such forward-looking statements. An investment in the Fund is speculative and involves a high degree of risk. Opportunities for withdrawal and transferability of interests are restricted. As a result, investors may not have access to capital except according to the terms of withdrawal specified within the confidential offering memorandum and other related documents. The fees and expenses that will be charged by the Fund and/or its Manager may be higher than the fees and expenses of other investment alternatives and may offset profits. With respect to the present email and/or its attachments, the Manager makes no warranty or representation, whether express or implied, and assumes no legal liability for the accuracy, completeness or usefulness of any information disclosed. In addition to exposure to adverse market conditions, investments may also be exposed to changes in regulations, change in providers of capital and other service providers. The Manager does not accept any responsibility or liability whatsoever caused by any action taken in reliance upon this email and/or its attachments. The private investment fund described herein has not been registered under any federal, state or foreign securities laws. These interests will be offered and sold only to "Accredited Investors" as such terms are defined under federal securities laws.